Thank you, Madam Chair.
Good morning, everyone.
I want to thank the witnesses for their presentation.
Mr. Gagnon, we used to have expertise in Quebec. We need only think of the Institut Armand-Frappier, which doesn't really seem to exist anymore. What happened and how can this help to show us that this isn't the way to go?
Over the past year, and even since the SARS crisis in 2003, we've missed many opportunities to develop our own expertise.
What hasn't been done, and what should we do from now on?